We at Scandinavian Biopharma are very proud to be an active participant in the endeavor to reduce child mortality and morbidity. We want to raise awareness of the leading causes of diarrhea and we are doing everything we can to develop a vaccine that will improve children’s chances of winning the fight against diarrheal disease. […]
The 2nd International Vaccines Against Shigella and ETEC (VASE) Conference will be held on June 12 to 14, in Mexico City, Mexico. Scientists, public health professionals, immunization leaders, vaccine industry representatives, international donors, and other experts around the globe will gather to share research and ideas toward making Shigella and enterotoxigenic Escherichia coli (ETEC) vaccines a reality. The aim of this collaborative, interactive gathering is […]
Scandinavian Biopharma continues to expand and strengthen its organization. In April Kyoko Misawa started as Clinical Study Manager at Scandinavian Biopharma’s research subsidiary ETVAX AB. Kyoko has more than 20 years’ experience from the pharmaceutical and life science industry in both Japan and Sweden within the field of diabetes, antibiotic, inflammation and orphan drugs. – […]
